Trial intelligence / Profile preview

Effect of sevoflurane preconditioning in cardiac ischemia during CABG

IRCT2016061528477N1Phase 3Completed

Sponsor
Bushehr University of Medical Sciences
Start
Mar 2015
Modality
Small Molecules
Countries
1
01

Overview

Phase 3 trial of sevoflurane in cardiac ischemia, myocardial ischemia-reperfusion injury and coronary arteriosclerosis (2 arms), sponsored by Bushehr University of Medical Sciences. Started Mar 2015; status: completed.

02

Drugs

sevoflurane
03

Conditions

cardiac ischemiamyocardial ischemia-reperfusion injurycoronary arteriosclerosis

Beyond the preview

Go deeper on IRCT2016061528477N1.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on IRCT2016061528477N1.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call